NewsRx

Search our medical news database

Gene Transfer (Hematopoietic Cells)

Retroviral Transduction Sustains Gene Expression In Progeny Cells

Published in Blood Weekly, August 10th, 1998

Murine stem cell virus (MSCV) efficiently transduced hematopoietic stem cells and gene expression was sustained through cell differentiation.

Two of the major problems associated with hematopoietic stem cell (HSC)-based gene therapy are inefficient gene transfer and insufficient gene expression in progeny cells derived from the transduced HSCs. The most commonly used retroviral vectors in clinical trials are Moloney murine leukemia virus (MoMLV) (R.G. Hawley et al., Transfus. Sci., 1996;17:7; and others).

Linzhao Cheng and colleagues from Osiris Therapeutics, Inc., Maryland, SyStemix, Inc., California, The Toronto Hospital, and the University of...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook